Annovis Bio (Annovis Bio) Price-to-Tangible-Book : (As of Apr. 25, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Annovis Bio Price-to-Tangible-Book?

As of today (2024-04-25), Annovis Bio's share price is $12.74. Annovis Bio's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-0.74. Hence, Annovis Bio's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Annovis Bio's Price-to-Tangible-Book or its related term are showing as below:

During the past 7 years, Annovis Bio's highest Price to Tangible Book Ratio was 6.89. The lowest was 3.20. And the median was 3.87.

ANVS's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.67
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Annovis Bio's share price is $12.74. Annovis Bio's Book Value per Sharefor the quarter that ended in Dec. 2023 was $-0.74. Hence, Annovis Bio's P/B Ratio of today is .

Annovis Bio Price-to-Tangible-Book Historical Data

The historical data trend for Annovis Bio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annovis Bio Price-to-Tangible-Book Chart

Annovis Bio Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

6.89

3.20

3.87

Annovis Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															3.87	6.29	6.21	12.84	-

Competitive Comparison of Annovis Bio's Price-to-Tangible-Book

For the Biotechnology subindustry, Annovis Bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annovis Bio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annovis Bio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Annovis Bio's Price-to-Tangible-Book falls into.

Annovis Bio Price-to-Tangible-Book Calculation

Annovis Bio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	12.74	/	-0.737
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Annovis Bio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Annovis Bio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Annovis Bio (Annovis Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annovis Bio Inc (NYSE:ANVS) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

07X:Germany

Address

1055 Westlakes Drive, Suite 300, Berwyn, PA, USA, 19312

Website

https://www.annovisbio.com

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.

Executives

Henry Iii Hagopian	officer: Chief Financial Officer	C/O ORGANOGENESIS INC., 85 DAN ROAD, CANTON MA 02021
Mark K. White	director	227 7TH AVENUE NE, ST. PETERSBURG FL 33701
Claudine Bruck	director	4995 BRADENTON AVE, SUITE 240, DUBLIN OH 43017-3552
Maria-luisa Maccecchini	director, officer: President and CEO	1223 FOXGLOVE LANE, WEST CHESTER PA 19380
Reid Mccarthy	director	1055 WESTLAKES DRIVE, SUITE 300, BERWYN PA 19312
Jeffrey Brian Mcgroarty	officer: Chief Financial Officer	360 HILLTOP RD, PAOLI PA 19301
Whelan, Jr. Robert M.	director	ARIAD PHARMACEUTICALS, INC., 26 LANDSDOWNE STREET, CAMBRIDGE MA 02139
Michael B Hoffman	director	1 GREENWICH OFFICE PARK, GREENWICH CT 06831